Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07674095
What this trial is testing

Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With Glioblastoma

Who this might be right for
Glioblastoma
BPGbio 150
Testing effectiveness (Phase 2)Looking for participantsNCT07569042
What this trial is testing

A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Malignant Neoplasm of Brain
Novelwise Pharmaceutical Corporation 15
Testing effectiveness (Phase 2)Study completedNCT00267592
What this trial is testing

Safety and Efficacy of Talampanel in Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc. 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04959500
What this trial is testing

Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Sun Yat-sen University 150
Early research (Phase 1)Study completedNCT01180816
What this trial is testing

Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 21
Testing effectiveness (Phase 2)Looking for participantsNCT06161974
What this trial is testing

Study of Olutasidenib and Temozolomide in HGG

Who this might be right for
High Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more
Rigel Pharmaceuticals 60
Very early researchStudy completedNCT05432375
What this trial is testing

Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Mundipharma Research Limited 10
Not applicableEnded earlyNCT02175745
What this trial is testing

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Who this might be right for
Adult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem Glioma+54 more
Erik Mittra 2
Early research (Phase 1)Study completedNCT02227901
What this trial is testing

Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 19
Early research (Phase 1)Looking for participantsNCT05083754
What this trial is testing

Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Testing effectiveness (Phase 2)Study completedNCT00919737
What this trial is testing

Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme

Who this might be right for
Malignant Glioma
Nobelpharma 24
Early research (Phase 1)Ended earlyNCT00895960
What this trial is testing

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

Who this might be right for
GlioblastomaCNS DiseaseBrain Diseases
M.D. Anderson Cancer Center 16
Not applicableStudy completedNCT04822688
What this trial is testing

Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues

Who this might be right for
GlioblastomaMalignant Solid Neoplasm
Thomas Jefferson University 141
Early research (Phase 1)Active Not RecruitingNCT06894979
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Childhood AstrocytomaChildhood Diffuse Intrinsic Pontine GliomaChildhood Diffuse Midline Glioma+2 more
Children's Oncology Group 54
Very early researchLooking for participantsNCT07485049
What this trial is testing

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

Who this might be right for
Glioblastoma (GBM)
Nader Sanai 78
Early research (Phase 1)Looking for participantsNCT07733674
What this trial is testing

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Radiomedix, Inc. 20
Early research (Phase 1)Ended earlyNCT00734526
What this trial is testing

Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT02861898
What this trial is testing

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerBrain Neoplasm+4 more
Northwell Health 33
Testing effectiveness (Phase 2)Ended earlyNCT00548938
What this trial is testing

Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM

Who this might be right for
Glioblastoma MultiformeHigh-Grade Glioma
Methodist Healthcare - Memphis 40
Testing effectiveness (Phase 2)Ended earlyNCT01898273
What this trial is testing

Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Cellectar Biosciences, Inc. 7
Next Page